APGE
Price
$40.59
Change
+$0.32 (+0.79%)
Updated
Mar 12, 01:38 PM (EDT)
Capitalization
2.34B
68 days until earnings call
ATXS
Price
$6.63
Change
+$0.16 (+2.47%)
Updated
Mar 12, 01:33 PM (EDT)
Capitalization
365.69M
57 days until earnings call
Ad is loading...

APGE vs ATXS

Header iconAPGE vs ATXS Comparison
Open Charts APGE vs ATXSBanner chart's image
Apogee Therapeutics
Price$40.59
Change+$0.32 (+0.79%)
Volume$307
Capitalization2.34B
Astria Therapeutics
Price$6.63
Change+$0.16 (+2.47%)
Volume$281
Capitalization365.69M
APGE vs ATXS Comparison Chart
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. ATXS commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and ATXS is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (APGE: $40.33 vs. ATXS: $6.48)
Brand notoriety: APGE and ATXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 156% vs. ATXS: 134%
Market capitalization -- APGE: $2.34B vs. ATXS: $365.69M
APGE [@Biotechnology] is valued at $2.34B. ATXS’s [@Biotechnology] market capitalization is $365.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileATXS’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • ATXS’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 4 TA indicator(s) are bullish while ATXS’s TA Score has 5 bullish TA indicator(s).

  • APGE’s TA Score: 4 bullish, 5 bearish.
  • ATXS’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, ATXS is a better buy in the short-term than APGE.

Price Growth

APGE (@Biotechnology) experienced а +32.80% price change this week, while ATXS (@Biotechnology) price change was +4.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.20%. For the same industry, the average monthly price growth was -6.76%, and the average quarterly price growth was -8.01%.

Reported Earning Dates

APGE is expected to report earnings on May 19, 2025.

ATXS is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.34B) has a higher market cap than ATXS($366M). APGE YTD gains are higher at: -10.971 vs. ATXS (-27.517). ATXS has higher annual earnings (EBITDA): -100.97M vs. APGE (-169.13M). APGE has more cash in the bank: 526M vs. ATXS (344M). ATXS has less debt than APGE: ATXS (5.64M) vs APGE (12.1M). APGE (0) and ATXS (0) have equivalent revenues.
APGEATXSAPGE / ATXS
Capitalization2.34B366M640%
EBITDA-169.13M-100.97M168%
Gain YTD-10.971-27.51740%
P/E RatioN/AN/A-
Revenue00-
Total Cash526M344M153%
Total Debt12.1M5.64M215%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGEATXS
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
78%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DQIRX29.84N/A
N/A
BNY Mellon Equity Income Fund I
FOVIX27.99N/A
N/A
First Trust/Confluence Small Cap Val I
MDFSX7.76N/A
N/A
Manning & Napier Disciplined Value S
MSQLX10.57N/A
N/A
Morgan Stanley Inst International Eq L
MKVGX14.46N/A
N/A
MFS International Large Cap Value R4

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+7.43%
SYRE - APGE
48%
Loosely correlated
-0.43%
ATXS - APGE
47%
Loosely correlated
+11.34%
KRYS - APGE
46%
Loosely correlated
+0.61%
KYMR - APGE
45%
Loosely correlated
+0.73%
ABOS - APGE
44%
Loosely correlated
+6.67%
More

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with KYMR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
+11.34%
KYMR - ATXS
48%
Loosely correlated
+0.73%
DNLI - ATXS
47%
Loosely correlated
+0.60%
CRNX - ATXS
46%
Loosely correlated
+1.48%
ABOS - ATXS
45%
Loosely correlated
+6.67%
IMNM - ATXS
45%
Loosely correlated
-1.36%
More